Pharma Focus Asia

BioSpark Labs Invests US$6 million to Open New Facility in Atlanta, USA

Introduction:
BioSpark Labs has invested US$6 million facility to support life sciences research in the Atlanta, USA.

Features:
The new facility now boasts a total usable footprint of 17,000 square feet. Within this space, five equipment rooms have been added, featuring US$1.5 million worth of shared life science research equipment. 

The facility includes advanced capabilities for flow cytometry, fluorescent imaging, real-time PCR testing, and cell culture.

The expansion also features a sizable shared laboratory, alongside two medium-sized and eight smaller private laboratories. 

In addition to these state-of-the-art research spaces, supplementary work areas and storage facilities have been incorporated to both entice and facilitate emerging researchers and to promote commercialisation within the bioscience industry. Furthermore, the additional cleanrooms are anticipated to become operational in early 2024.

Phase one, encompassing the Science Square Labs building, the apartment community, and a new parking deck, is on track for its scheduled completion in March 2024.

Specifications:

Name     BioSpark Labs
Type       New Construction
Budget   US$6 million
Year       2024

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference